Free Trial

Joseph Pantginis Analyst Performance

Managing Director of Equity Research at HC Wainwright

Joseph Pantginis is a stock analyst at HC Wainwright in the healthcare sector, covering 90 publicly traded companies. Over the past year, Joseph Pantginis has issued 104 stock ratings, including strong buy, buy, and hold recommendations. While full access to Joseph Pantginis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joseph Pantginis' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
976 Last 12 Years
Buy Recommendations
94.20% 909 Buy Ratings
Companies Covered
90 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.4%4 ratings
Buy93.8%905 ratings
Hold5.8%56 ratings
Sell0.0%0 ratings

Out of 965 total stock ratings issued by Joseph Pantginis at HC Wainwright, the majority (93.8%) have been Buy recommendations, followed by 5.8% Hold and 0.4% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.6% of companies on NASDAQ
68 companies
OTCMKTS
12.2% of companies on OTCMKTS
11 companies
NYSEAMERICAN
5.6% of companies on NYSEAMERICAN
5 companies
TSE
3.3% of companies on TSE
3 companies
NYSE
2.2% of companies on NYSE
2 companies
CVE
1.1% of companies on CVE
1 company

Joseph Pantginis, an analyst at HC Wainwright, currently covers 90 companies listed on NASDAQ, OTCMKTS, NYSEAMERICAN, TSE, NYSE and CVE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
90 companies
100.0%

Joseph Pantginis of HC Wainwright specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
68 companies
75.6%
PHARMACEUTICALS
19 companies
21.1%
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies
2.2%
LIFE SCIENCES TOOLS & SERVICES
1 company
1.1%

About Joseph Pantginis

Dr. Pantginis is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the healthcare sector. Dr. Pantginis conducted more than seventeen years of healthcare equity research. Prior to joining H.C. Wainwright, Dr. Pantginis worked as a Senior Research Analyst and Head of Biotechnology Research at ROTH Capital Partners. Dr. Pantginis also held senior positions at Merriman, Canaccord Adams, Commerce Capital Markets, JBHanauer and Ladenburg. Prior to his equity research career, Dr. Pantginis worked at Regeneron Pharmaceuticals, where he founded the Retroviral Core Facility. Dr. Pantginis’ educational background includes both a Ph.D. and an M.S. in molecular genetics from the Albert Einstein College of Medicine as well as an MBA from Pace University.
Follow on LinkedIn

Joseph Pantginis' Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
ODTX
Odyssey Therapeutics
11/6/2026Initiated Coverage$18.88$40.00Buy
KARD
Kardigan
11/4/2026Initiated Coverage$14.32$42.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
10/19/2026Reiterated Rating$62.45$140.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
10/19/2026Reiterated Rating$46.70$85.00Buy
Clene Inc. stock logo
CLNN
Clene
10/19/2026Reiterated Rating$3.24Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
10/15/2026Reiterated Rating$331.65$361.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
10/14/2026Reiterated Rating$1.26$4.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
10/2/2026Reiterated Rating$32.18$64.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
9/29/2026Boost Price Target$13.75$20.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
9/24/2026Reiterated Rating$21.02$39.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
9/24/2026Reiterated Rating$298.64$358.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
9/22/2026Reiterated Rating$38.37Buy
Armata Pharmaceuticals, Inc. stock logo
ARMP
Armata Pharmaceuticals
9/22/2026Reiterated Rating$4.26$15.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
9/22/2026Reiterated Rating$54.99$95.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
9/22/2026Boost Price Target$33.50$64.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
9/22/2026Reiterated Rating$62.86$67.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
9/22/2026Reiterated Rating$11.07$37.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
9/14/2026Reiterated Rating$11.21$37.00Buy
Adlai Nortye Ltd. Sponsored ADR stock logo
ANL
Adlai Nortye
9/8/2026Reiterated Rating$15.62$20.00Buy
Sinovac Biotech, Ltd. stock logo
SVA
Sinovac Biotech
9/8/2026Reiterated Rating$6.47$1.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
8/31/2026Reiterated Rating$72.09$140.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
8/26/2026Reiterated Rating$0.22Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
8/24/2026Reiterated Rating$56.98$95.00Buy
BioCardia, Inc. stock logo
BCDA
BioCardia
8/24/2026Reiterated Rating$1.00Buy
Clene Inc. stock logo
CLNN
Clene
8/17/2026Reiterated Rating$4.14Buy
OmniAb, Inc. stock logo
OABI
OmniAb
8/17/2026Reiterated Rating$3.93$11.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
8/14/2026Reiterated Rating$41.66$85.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
8/14/2026Reiterated Rating$73.45Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
8/11/2026Lower Price Target$7.23$14.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
8/6/2026Boost Price Target$312.13$358.00Buy
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
7/28/2026Boost Price Target$15.21$36.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
7/27/2026Downgrade$7.00Neutral
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
7/14/2026Reiterated Rating$1.22Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
6/22/2026Boost Price Target$13.80$39.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
6/16/2026Boost Price Target$322.09$361.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
6/15/2026Reiterated Rating$31.27$42.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
6/12/2026Boost Price Target$10.67$13.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
6/10/2026Initiated Coverage$51.63$95.00Buy
BioCardia, Inc. stock logo
BCDA
BioCardia
6/9/2026Reiterated Rating$0.92$25.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
6/8/2026Reiterated Rating$4.93$18.00Buy
Pentagon magnet restrictions take effect January 1, 2027 (Ad)

A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel

Read the full breakdown of the proposed Army rare earth agreement and the company behind it.
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
6/4/2026Reiterated Rating$9.40$96.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
6/2/2026Boost Price Target$43.12$67.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
6/2/2026Reiterated Rating$29.86$57.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
6/1/2026Reiterated Rating$309.03$310.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
5/22/2026Reiterated Rating$29.19$57.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/18/2026Reiterated Rating$306.29$310.00Buy
ProKidney Corp. stock logo
PROK
ProKidney
5/18/2026Reiterated Rating$1.63$12.00Buy
Lisata Therapeutics, Inc. stock logo
LSTA
Lisata Therapeutics
5/15/2026Downgrade$3.19Neutral
Neuphoria Therapeutics Inc. stock logo
NEUP
Neuphoria Therapeutics
5/15/2026Downgrade$4.74Neutral
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
5/13/2026Reiterated Rating$31.52$60.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/11/2026Boost Price Target$76.91$140.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
5/5/2026Boost Price Target$44.91$57.00Buy
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
5/5/2026Reiterated Rating$5.00$13.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/4/2026Reiterated Rating$278.00$310.00Buy
Clene Inc. stock logo
CLNN
Clene
5/4/2026Reiterated Rating$6.71$31.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
5/1/2026Downgrade$3.12$3.16Neutral
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
4/30/2026Downgrade$40.99$39.00Neutral
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
4/30/2026Boost Price Target$224.86$289.00Buy
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
4/27/2026Reiterated Rating$1.92$24.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
4/24/2026Reiterated Rating$6.97$96.00Buy
Adlai Nortye Ltd. Sponsored ADR stock logo
ANL
Adlai Nortye
4/20/2026Boost Price Target$16.01$20.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
4/20/2026Boost Price Target$7.53$18.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
4/15/2026Reiterated Rating$1.29$15.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
4/14/2026Reiterated Rating$30.70$47.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
4/14/2026Boost Price Target$230.97$243.00Buy
Cadrenal Therapeutics, Inc. stock logo
CVKD
Cadrenal Therapeutics
4/7/2026Lower Price Target$4.35$13.00Buy
Aprea Therapeutics, Inc. stock logo
APRE
Aprea Therapeutics
3/31/2026Lower Price Target$0.74$1.20Buy
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
3/24/2026Reiterated Rating$1.44$9.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
3/24/2026Reiterated Rating$16.08$37.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
3/23/2026Reiterated Rating$32.33$102.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/23/2026Reiterated Rating$1.63$6.00Buy
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
3/20/2026Reiterated Rating$28.76$97.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/12/2026Set Price Target$1.70$6.00
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
3/12/2026Set Price Target$15.64$37.00Buy
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
3/10/2026Reiterated Rating$6.01$13.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
3/10/2026Reiterated Rating$2.73Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
3/10/2026Reiterated Rating$35.61$60.00Buy
BiomX Inc. stock logo
PHGE
BiomX
3/9/2026Downgrade$7.10Hold
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
3/6/2026Reiterated Rating$1.91Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/5/2026Boost Price Target$1.68$6.00Buy
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
2/25/2026Initiated Coverage$4.50$13.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
2/24/2026Boost Price Target$189.97$239.00Buy
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
2/23/2026Reiterated Rating$3.66$17.00Buy
Armata Pharmaceuticals, Inc. stock logo
ARMP
Armata Pharmaceuticals
2/23/2026Boost Price Target$9.25$15.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
2/19/2026Upgrade$34.63Strong-Buy
Adlai Nortye Ltd. Sponsored ADR stock logo
ANL
Adlai Nortye
2/13/2026Upgrade$9.64$16.00Buy
Aprea Therapeutics, Inc. stock logo
APRE
Aprea Therapeutics
1/29/2026Reiterated Rating$0.58$4.00Buy
CalciMedica Inc. stock logo
CALC
CalciMedica
1/29/2026Reiterated Rating$1.25Neutral
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
1/13/2026Reiterated Rating$9.17$40.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
1/9/2026Reiterated Rating$248.91$310.00Buy
Your father's savings lost half their value after 1971. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
12/22/2025Boost Price Target$62.72$136.00Buy
Aprea Therapeutics, Inc. stock logo
APRE
Aprea Therapeutics
12/18/2025Lower Price Target$0.92$5.00Buy
ProKidney Corp. stock logo
PROK
ProKidney
12/16/2025Initiated Coverage$2.08$12.00Buy
ProKidney Corp. stock logo
PROK
ProKidney
12/16/2025Initiated Coverage$2.20$12.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
12/12/2025Lower Price Target$0.79$3.00Buy
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
12/11/2025Lower Price Target$26.13$97.00Buy
Neuphoria Therapeutics Inc. stock logo
NEUP
Neuphoria Therapeutics
12/5/2025Lower Price Target$4.27$7.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
12/3/2025Boost Price Target$27.67$60.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
12/3/2025Reiterated Rating$5.81Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
12/2/2025Reiterated Rating$17.70$96.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
12/1/2025Upgrade$2.06$6.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
11/28/2025Reiterated Rating$36.26$47.00Buy
BiomX Inc. stock logo
PHGE
BiomX
11/25/2025Boost Price Target$2.90$260.00Buy
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
11/24/2025Reiterated Rating$1.75$9.00Buy
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
11/14/2025Reiterated Rating$10.68$40.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
11/13/2025Boost Price Target$0.85$15.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
11/6/2025Boost Price Target$208.50$231.00Buy
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
10/30/2025Downgrade$10.06Neutral
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
10/29/2025Lower Price Target$2.07$9.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
10/20/2025Initiated Coverage$36.40$52.00Buy
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
10/20/2025Reiterated Rating$9.84$40.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
10/20/2025Initiated Coverage$37.66$52.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
10/16/2025Downgrade$11.92Hold
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
10/8/2025Reiterated Rating$27.36$57.00Buy
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
9/30/2025Reiterated Rating$8.97$40.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
9/29/2025Reiterated Rating$25.65$102.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
9/29/2025Reiterated Rating$52.79$120.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
9/26/2025Lower Price Target$15.86$96.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
9/25/2025Reiterated Rating$6.47$24.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
9/22/2025Reiterated Rating$48.66$120.00Buy
BioCardia, Inc. stock logo
BCDA
BioCardia
9/22/2025Reiterated Rating$1.13$25.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
9/19/2025Reiterated Rating$24.19$47.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
9/19/2025Reiterated Rating$2.75$16.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
9/17/2025Boost Price Target$7.76$20.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
9/15/2025Initiated Coverage$12.24$108.00Buy
aTyr Pharma, Inc. stock logo
ATYR
aTyr Pharma
9/15/2025Downgrade$1.12Neutral
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
9/15/2025Reiterated Rating$153.21$240.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
9/11/2025Reiterated Rating$6.30$24.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
9/10/2025Reiterated Rating$27.53$47.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
9/3/2025Reiterated Rating$19.40$47.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
9/2/2025Reiterated Rating$1.13$5.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
9/2/2025Reiterated Rating$1.11$4.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
8/28/2025Boost Price Target$17.44$47.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
8/28/2025Boost Price Target$160.51$206.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
8/27/2025Reiterated Rating$1.08$5.00Buy
Neuphoria Therapeutics Inc. stock logo
NEUP
Neuphoria Therapeutics
8/26/2025Reiterated Rating$7.40$21.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/22/2025Reiterated Rating$145.70$240.00Buy
Lisata Therapeutics, Inc. stock logo
LSTA
Lisata Therapeutics
8/21/2025Reiterated Rating$2.40$15.00Buy
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
8/21/2025Lower Price Target$2.05$17.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
8/20/2025Lower Price Target$24.02$42.00Buy
Your Copy is on Hold (Claim it now) (Ad)

James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel

Claim your copy of James Altucher's new Elon Musk report today.
BiomX Inc. stock logo
PHGE
BiomX
8/20/2025Reiterated Rating$104.12$2,850.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
8/19/2025Reiterated Rating$2.50$20.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
8/19/2025Reiterated Rating$23.90$102.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
8/13/2025Reiterated Rating$6.65$16.00Buy
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
8/5/2025Reiterated Rating$8.20$30.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
8/4/2025Lower Price Target$7.01$10.00Buy
Yarrow Bioscience stock logo
YARW
Yarrow Bioscience
7/30/2025Downgrade$0.39Neutral
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
7/25/2025Reiterated Rating$150.00$240.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
7/11/2025Lower Price Target$7.94$24.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
7/1/2025Reiterated Rating$14.80$30.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
7/1/2025Reiterated Rating$1.33$13.00Buy
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
6/30/2025Initiated Coverage$13.17$42.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
6/25/2025Reiterated Rating$26.08$102.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
6/24/2025Reiterated Rating$0.73$4.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
6/24/2025Reiterated Rating$1.52$4.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
6/24/2025Reiterated Rating$8.47$77.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
6/24/2025Reiterated Rating$143.72$240.00Buy
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
6/23/2025Reiterated Rating$0.95$9.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
6/18/2025Upgrade$22.10$41.00Buy
BioLineRx Ltd. stock logo
BLRX
BioLineRx
6/17/2025Reiterated Rating$4.67Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
6/17/2025Reiterated Rating$1.17$16.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
6/13/2025Reiterated Rating$20.35$50.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
6/13/2025Reiterated Rating$12.51$77.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
6/13/2025Reiterated Rating$5.89$16.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
6/11/2025Reiterated Rating$1.68$13.00Buy
Moleculin Biotech, Inc. stock logo
MBRX
Moleculin Biotech
6/9/2025Upgrade$335.00$2,000.00Buy
Phio Pharmaceuticals Corp. stock logo
PHIO
Phio Pharmaceuticals
6/5/2025Initiated Coverage$2.10$14.00Buy
aTyr Pharma, Inc. stock logo
ATYR
aTyr Pharma
6/4/2025Reiterated Rating$212.60$1,400.00Buy
Adlai Nortye Ltd. Sponsored ADR stock logo
ANL
Adlai Nortye
6/2/2025Downgrade$1.57Neutral
BioLineRx Ltd. stock logo
BLRX
BioLineRx
5/28/2025Reiterated Rating$3.68Buy
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
5/28/2025Reiterated Rating$24.92$104.00Buy
Curis, Inc. stock logo
CRIS
Curis
5/19/2025Reiterated Rating$40.60$340.00Buy
aTyr Pharma, Inc. stock logo
ATYR
aTyr Pharma
5/19/2025Reiterated Rating$130.80$1,400.00Buy
Armata Pharmaceuticals, Inc. stock logo
ARMP
Armata Pharmaceuticals
5/19/2025Boost Price Target$1.74$9.00Buy
BiomX Inc. stock logo
PHGE
BiomX
5/16/2025Lower Price Target$107.10$2,850.00Buy
Cadrenal Therapeutics, Inc. stock logo
CVKD
Cadrenal Therapeutics
5/16/2025Reiterated Rating$15.14$32.00Buy
CalciMedica Inc. stock logo
CALC
CalciMedica
5/15/2025Reiterated Rating$9.57$80.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
5/12/2025Reiterated Rating$1.55$4.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
5/9/2025Lower Price Target$3.17$20.00Buy
Iterum Therapeutics PLC stock logo
ITRM
Iterum Therapeutics
5/8/2025Reiterated Rating$0.92$9.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
5/6/2025Lower Price Target$2.00$18.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
5/6/2025Reiterated Rating$20.29$80.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/6/2025Reiterated Rating$141.18$240.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
4/30/2025Reiterated Rating$10.33$15.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
4/28/2025Boost Price Target$167.35$240.00Buy
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
4/28/2025Reiterated Rating$6.41$40.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
4/28/2025Reiterated Rating$1.34$4.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
4/25/2025Reiterated Rating$0.46$5.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
4/25/2025Reiterated Rating$0.88$16.00Buy
Yarrow Bioscience stock logo
YARW
Yarrow Bioscience
4/25/2025Lower Price Target$69.50$225.00Buy
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
4/24/2025Reiterated Rating$25.84$102.00Buy
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
4/21/2025Reiterated Rating$1.78$24.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
4/21/2025Reiterated Rating$38.01$120.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
4/17/2025Reiterated Rating$23.45$102.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
4/15/2025Reiterated Rating$39.07$120.00Buy
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
4/10/2025Reiterated Rating$7.15$16.00Neutral
Xenetic Biosciences, Inc. stock logo
XBIO
Xenetic Biosciences
4/9/2025Reiterated Rating$2.38Neutral
Clene Inc. stock logo
CLNN
Clene
4/8/2025Reiterated Rating$2.99$31.00Buy
BiomX Inc. stock logo
PHGE
BiomX
4/4/2025Reiterated Rating$111.34$3,990.00Buy
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
4/4/2025Boost Price Target$1.61$24.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
4/4/2025Reiterated Rating$40.52$120.00Buy
Kairos Pharma, Ltd. stock logo
KAPA
Kairos Pharma
4/3/2025Initiated Coverage$6.43$84.00Buy
BiomX Inc. stock logo
PHGE
BiomX
4/1/2025Boost Price Target$105.58$3,990.00Buy
CalciMedica Inc. stock logo
CALC
CalciMedica
4/1/2025Reiterated Rating$9.55$80.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
4/1/2025Reiterated Rating$1.61$4.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
3/31/2025Reiterated Rating$2.30$40.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/31/2025Reiterated Rating$0.61$5.00Buy
BioLineRx Ltd. stock logo
BLRX
BioLineRx
3/31/2025Boost Price Target$3.03$26.00Buy
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
3/28/2025Reiterated Rating$20.97$104.00Buy
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
3/28/2025Lower Price Target$10.92$208.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/28/2025Reiterated Rating$0.63$4.00Buy
Aptose Biosciences Inc. stock logo
APTO
Aptose Biosciences
3/28/2025Boost Price Target$3.33$6.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
3/27/2025Lower Price Target$1.25$13.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
3/27/2025Reiterated Rating$1.07Neutral
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
3/26/2025Reiterated Rating$26.07$102.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
3/25/2025Reiterated Rating$1.73$4.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
3/24/2025Reiterated Rating$2.87$40.00Buy
Clene Inc. stock logo
CLNN
Clene
3/24/2025Reiterated Rating$4.06$31.00Buy
Xenetic Biosciences, Inc. stock logo
XBIO
Xenetic Biosciences
3/20/2025Reiterated Rating$3.64Neutral
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
3/20/2025Reiterated Rating$8.86$37.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
3/20/2025Reiterated Rating$1.62$16.00Buy
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
3/19/2025Reiterated Rating$20.89$104.00Buy
OmniAb, Inc. stock logo
OABI
OmniAb
3/19/2025Reiterated Rating$3.19$11.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
3/18/2025Reiterated Rating$1.24$4.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
3/17/2025Reiterated Rating$13.23$77.00Buy
aTyr Pharma, Inc. stock logo
ATYR
aTyr Pharma
3/14/2025Reiterated Rating$159.60$1,400.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
3/14/2025Reiterated Rating$8.74$37.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
3/13/2025Reiterated Rating$1.27$21.00Buy
Clene Inc. stock logo
CLNN
Clene
3/12/2025Reiterated Rating$4.41$31.00Buy
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
3/11/2025Reiterated Rating$0.53$9.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/11/2025Lower Price Target$0.51$5.00Buy
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
3/11/2025Reiterated Rating$1.12$4.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
3/11/2025Reiterated Rating$25.36$102.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
3/11/2025Reiterated Rating$5.91$16.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
3/7/2025Reiterated Rating$1.28$21.00Buy
Yarrow Bioscience stock logo
YARW
Yarrow Bioscience
3/6/2025Reiterated Rating$115.50$287.50Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
3/5/2025Reiterated Rating$22.08$57.00Buy
CalciMedica Inc. stock logo
CALC
CalciMedica
3/4/2025Reiterated Rating$11.00$80.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
3/4/2025Reiterated Rating$1.76$16.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
3/4/2025Reiterated Rating$14.23$77.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/3/2025Reiterated Rating$0.35$4.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
2/28/2025Reiterated Rating$5.26$32.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
2/28/2025Reiterated Rating$20.31$80.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2/28/2025Reiterated Rating$47.45$120.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/28/2025Reiterated Rating$176.56$221.00Buy
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
2/27/2025Reiterated Rating$7.77$40.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
2/27/2025Reiterated Rating$6.45$16.00Buy
Clene Inc. stock logo
CLNN
Clene
2/25/2025Reiterated Rating$4.33$31.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
2/25/2025Lower Price Target$7.06$11.00Buy
PDS Biotechnology Corporation stock logo
PDSB
PDS Biotechnology
2/24/2025Reiterated Rating$1.23$21.00Buy
Yarrow Bioscience stock logo
YARW
Yarrow Bioscience
2/19/2025Reiterated Rating$131.90$287.50Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/19/2025Reiterated Rating$171.70$221.00Buy
Palatin Technologies, Inc. stock logo
PTNT
Palatin Technologies
2/13/2025Lower Price Target$54.25$350.00Buy
Aptose Biosciences Inc. stock logo
APTO
Aptose Biosciences
2/12/2025Reiterated Rating$6.70$60.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
2/11/2025Reiterated Rating$1.86$16.00Buy
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
2/11/2025Reiterated Rating$0.64$9.00Buy
Palatin Technologies, Inc. stock logo
PTNT
Palatin Technologies
2/7/2025Reiterated Rating$49.50$850.00Buy
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
2/6/2025Boost Price Target$9.05$40.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
2/6/2025Reiterated Rating$33.50$102.00Buy
Neuphoria Therapeutics Inc. stock logo
NEUP
Neuphoria Therapeutics
2/4/2025Boost Price Target$5.10$21.00Buy
XOMA Royalty Corporation stock logo
XOMA
XOMA Royalty
2/3/2025Lower Price Target$26.61$104.00Buy
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
1/31/2025Reiterated Rating$0.63$9.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
1/29/2025Reiterated Rating$0.93$4.00Buy
Palatin Technologies, Inc. stock logo
PTNT
Palatin Technologies
1/28/2025Reiterated Rating$46.50$850.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
1/23/2025Reiterated Rating$2.20$16.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
1/23/2025Reiterated Rating$7.53$16.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
1/22/2025Reiterated Rating$21.29$57.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
1/21/2025Reiterated Rating$45.72$120.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
1/17/2025Reiterated Rating$33.66$102.00Buy
Aprea Therapeutics, Inc. stock logo
APRE
Aprea Therapeutics
1/15/2025Reiterated Rating$3.77$20.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
1/14/2025Reiterated Rating$1.50$18.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
1/14/2025Reiterated Rating$17.11$57.00Buy
Yarrow Bioscience stock logo
YARW
Yarrow Bioscience
1/14/2025Reiterated Rating$151.00$287.50Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
1/14/2025Reiterated Rating$4.15$40.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
1/13/2025Reiterated Rating$7.27$16.00Buy
Aptose Biosciences Inc. stock logo
APTO
Aptose Biosciences
1/10/2025Reiterated Rating$6.40$60.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
1/10/2025Reiterated Rating$2.17Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
1/10/2025Reiterated Rating$47.37$120.00Buy
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
1/8/2025Reiterated Rating$41.52$102.00Buy
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
1/8/2025Reiterated Rating$1.77$10.00Buy
BiomX Inc. stock logo
PHGE
BiomX
1/8/2025Reiterated Rating$140.51$380.00Buy